Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario de la Princesa (52)

2024

  1. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors

    Biomedicine and Pharmacotherapy, Vol. 174

  2. Usefulness of Procalcitonin Levels for Predicting the Microbiological Orientation in Patients with Sepsis

    Journal of Personalized Medicine, Vol. 14, Núm. 2

2023

  1. Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors

    Cancers, Vol. 15, Núm. 4

  2. Usefulness of Preoperative Determination of Serum MR-ProAdrenomedullin Levels to Predict the Need for Postoperative Organ Support in Abdominal Oncological Surgery

    Journal of Personalized Medicine, Vol. 13, Núm. 7

2022

  1. Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

    Haematologica, Vol. 107, Núm. 11, pp. 2675-2684

  2. Microsomal prostaglandin E synthase-1 is involved in the metabolic and cardiovascular alterations associated with obesity

    British Journal of Pharmacology, Vol. 179, Núm. 11, pp. 2733-2753

  3. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  4. Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

    Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270

2021

  1. Gestion del proceso posanalitico en los laboratorios clinicos segun los requisitos de la norma ISO 15189:2012. Consideraciones sobre la gestion de muestras clinicas, aseguramiento de la calidad en el proceso posanalitico y gestion de la informacion del laboratorio

    Advances in Laboratory Medicine, Vol. 2, Núm. 3, pp. 381-389

  2. Gestión del proceso posanalítico en los laboratorios clínicos según los requisitos de la norma ISO 15189:2012. Consideraciones sobre la revisión, notificación y comunicación de los resultados

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 61-70

  3. Management of post-Analytical processes in the clinical laboratory according to ISO 15189:2012. Considerations about the management of clinical samples, ensuring quality of post-Analytical processes, and laboratory information management

    Advances in Laboratory Medicine, Vol. 2, Núm. 3, pp. 373-380

  4. Management of postanalytical processes in the clinical laboratory according to ISO 15189:2012 Standard requirements: Considerations on the review, reporting and release of results

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 51-59

2020

  1. Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis

    Cell Death and Disease, Vol. 11, Núm. 8

  2. Myeloid GRK2 regulates obesity-induced endothelial dysfunction by modulating inflammatory responses in perivascular adipose tissue

    Antioxidants, Vol. 9, Núm. 10, pp. 1-17

  3. The interaction between mitochondrial oxidative stress and gut microbiota in the cardiometabolic consequences in diet-induced obese rats

    Antioxidants, Vol. 9, Núm. 7, pp. 1-15

2019

  1. Three-dimensional Tricuspid Area. A New Criterion to Improve Patient Selection for Annuloplasty in Tricuspid Regurgitation

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 732-739

2017

  1. Corrigendum to "T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage"

    BioMed research international

  2. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

    British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265

2015

  1. Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program

    American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433

  2. Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis

    EMBO Molecular Medicine, Vol. 7, Núm. 1, pp. 102-123